The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence

Eoghan M McCarthy, Emily Sutton, Stephanie Nesbit, Ben Parker, David Jayne, Bridget Griffiths, David A Isenberg, Anisur Rahman, Caroline Gordon, David P D'Cruz, Benjamin Rhodes, Peter Lanyon, Edward M Vital, Chee-Seng Yee, Christopher J Edwards, Lee-Suan Teh, Mohammed Akil, Neil J McHugh, Asad Zoma, Ian N BruceBritish Isles Lupus Assessment Group Biologics Register

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)1041-1043
Number of pages3
JournalRheumatology
Volume56
Issue number6
Early online date18 Apr 2017
DOIs
Publication statusPublished - 1 Jun 2017

Keywords

  • Journal Article

Cite this

McCarthy, E. M., Sutton, E., Nesbit, S., Parker, B., Jayne, D., Griffiths, B., ... British Isles Lupus Assessment Group Biologics Register (2017). The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence. Rheumatology, 56(6), 1041-1043. https://doi.org/10.1093/rheumatology/kex044